We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

6186:HKEXChina Feihe Limited Analysis

Data as of 2026-06-22 - not real-time

¥371.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Ichikura Co., Ltd. is trading at ¥371, just above the 20‑day SMA of ¥373.6 and well below the 200‑day SMA of ¥381.6, indicating a short‑term price weakness within a longer‑term bearish backdrop. The RSI sits near 45, suggesting neutral momentum, while the MACD histogram is modestly positive (+0.064) and the MACD line has crossed above its signal, offering a faint bullish signal amid the prevailing downtrend. Volatility over the past 30 days is 11.7% and the beta is extremely low at 0.12, meaning price swings are relatively muted compared with the market. On the valuation side, the forward P/E of 2.41, P/B of 0.76 and price‑to‑sales of 0.11 place the stock far below its DCF‑derived fair value of ¥3,019, flagging a deep discount. The company delivers a generous 4.29% dividend yield with a payout ratio under 40%, supported by positive free cash flow of roughly ¥1.2 bn. However, earnings are currently negative (trailing EPS ≈ ‑¥261) and the balance sheet is leveraged, with a debt‑to‑equity ratio above 166, which tempers the upside potential.
Given the increasing volume, modest bullish MACD, and attractive dividend, the stock may attract value‑oriented investors seeking yield, but the lingering profitability concerns and high leverage suggest caution. The bearish technical trend and proximity to the identified support level of ¥359 mean downside risk remains in the near term. Over the medium horizon, the substantial valuation gap and stable cash generation could support a price rebound, provided the company can stabilize earnings. In the long run, the fundamental turnaround risk is significant, but if Ichikura can improve margins and reduce debt, the current discount could translate into meaningful returns.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical trend with price near support
  • Neutral momentum (RSI ~45) and modest bullish MACD
  • Attractive dividend yield but earnings are negative

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Deep valuation discount versus DCF fair value
  • Low forward P/E and P/B ratios
  • Sustainable dividend supported by strong free cash flow

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential upside if profitability improves
  • High dividend yield providing income cushion
  • Low market beta reducing systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth-1.30%
Profit Margin-7.41%
P/E Ratio2.4
ROE-40.67%
ROA-0.43%
Debt/Equity166.73
P/B Ratio0.8
Op. Cash Flow¥1.3B
Free Cash Flow¥1.2B

Technical Analysis

TrendBearish
RSI45.0
Support¥359.00
Resistance¥380.00
MA 20¥373.60
MA 50¥374.40
MA 200¥381.56
MACDBullish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

Fair Value¥3,018.96
GradeUndervalued
TypeValue
Dividend Yield4.29%

Risk Assessment

Beta0.12
Volatility11.66%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.